Reply to Huang et al

Affiliations

Comment

Riccardo Utili et al. Clin Infect Dis. 2014 Jan.

. 2014 Jan;58(1):142-3.

doi: 10.1093/cid/cit635. Epub 2013 Sep 30.

¹ Internal Medicine, University of Naples S.U.N. and Monaldi Hospital, Naples, Italy.

No abstract available

Comment on

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R. Durante-Mangoni E, et al. Clin Infect Dis. 2013 Aug;57(3):349-58. doi: 10.1093/cid/cit253. Epub 2013 Apr 24. Clin Infect Dis. 2013. PMID: 23616495 Clinical Trial.
Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii.
Huang DB, Pastagia M, Chiang T. Huang DB, et al. Clin Infect Dis. 2014 Jan;58(1):141-2. doi: 10.1093/cid/cit630. Epub 2013 Sep 30. Clin Infect Dis. 2014. PMID: 24081682 No abstract available.